These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10701314)

  • 1. [AIDS: new FDA approved agents].
    Forstenlehner M
    Pharm Unserer Zeit; 2000 Jan; 29(1):58. PubMed ID: 10701314
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 5. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA looks at full approval for d4T. Food and Drug Administration.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibitor-sparing regimen suppresses HIV.
    AIDS Patient Care STDS; 1998 Dec; 12(12):940. PubMed ID: 11362068
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y; Vivet-Boudou V; Marquet R
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three generic stavudine formulations approved.
    AIDS Patient Care STDS; 2009 Feb; 23(2):135. PubMed ID: 19236160
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic combination approved.
    AIDS Patient Care STDS; 2009 Mar; 23(3):219. PubMed ID: 19302019
    [No Abstract]   [Full Text] [Related]  

  • 12. [Approval of a new nucleoside. Component of complete once daily regimen].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373067
    [No Abstract]   [Full Text] [Related]  

  • 13. Stavudine-based multiple agent combinations: initial studies and ongoing comparative trials.
    Murphy RL
    Antivir Ther; 1998; 3 Suppl 4():69-73. PubMed ID: 10723516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing open-label trials of triple therapy with stavudine and lamivudine or stavudine and didanosine plus nelfinavir.
    Anderson RD
    Antivir Ther; 1998; 3 Suppl 4():63-4. PubMed ID: 10723514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 18. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Wool M
    Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.